LipiDiDiet finds long-lasting and broad effects of nutritional intervention in early Alzheimer’s

There is no known cure for dementia at the present time and existing drug therapies have to focus on treating the symptoms of the disease. However, if patients with early-stage Alzheimer’s disease are given a medical nutrition drink containing a multinutrient formulation, the impact of the disease can be slowed. Trial participants who received a multinutrient formulation over an extended period of time showed a significantly less rapid deterioration in cognitive performance than the patients in a control group, who received only a placebo. These findings are from an ongoing European study LipiDiDiet in which 311 patients in eleven hospitals have been monitored for three years.

Quelle: IDW Informationsdienst Wissenschaft